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Abstract
Background: When keratinized tissue width around dental implants is poorly represented, the clinician could resort
to autogenous soft tissue grafting. Autogenous soft tissue grafting procedures are usually associated with a certain
degree of morbidity. Collagen matrices could be used as an alternative to reduce morbidity and intra-operatory
times. The aim of this study was to assess the efficacy of a xenogeneic collagen matrix as a substitute for soft tissue
grafting around dental implants.
Methods: Fifteen consecutive patients underwent a vestibuloplasty and keratinized tissue reconstruction around
dental implants, both in the mandible and the maxilla, with a porcine collagen matrix. The so obtained
keratinized tissues were measured and evaluated after 6 months and 1, 4, and 5 years.
Results: The average gain of keratinized tissue was 5.7 mm. After 6 months, it was observed a resorption of 37%, after
1 year 48%, and after 5 years 59%. The mean gain of keratinized tissue after 5 years was 2.4 mm. Hemostatic effect and
post-operative pain were evaluated too. All subjects referred minimal pain with no bleeding. No adverse reaction nor
infection was noted.
Conclusions: The present study showed the efficacy of a porcine collagen matrix in keratinized tissue augmentation.
The possibility to use a soft tissue substitute is a great achievement as morbidity decreases and bigger areas can be
treated in a single surgery.
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Background
A variety of factors can lead to teeth loss. From peri-
odontal disease to trauma, the bone remodeling that al-
ways follows this event can complicate the subsequent
prosthetical rehabilitation [1]. Both removable and implant-
fixed restorations require both an adequate quantity of
bone and sorrounding soft tissue. Even in severe atrophies
of the jaw, nowadays, many bone augmentation techniques
are applicable, all with an acceptable long-term stability [2].
Unfortunately, these techniques, especially in major recon-
structions, lead to a deficient quantity of soft tissue, above
all keratinized mucosa. Whether or not the presence of
keratinized tissue around dental implants is necessary, it
has been controversial for many years. The lack of evidence
in literature regarding implant survival rate in absence of
keratinized tissue cannot lead to any conclusion [3]. None-
theless, the presence of this kind of tissue is desirable for a
number of reasons, as shown by many authors. A retro-
spective study, based on 339 implants, showed that a lack
of keratinized tissue around dental implants, especially in
the posterior region, led to higher plaque accumulation and
mucositis [4]. Thin or narrow (< 1 mm) peri-implant kerati-
nized mucosa was shown to have a higher association
with mucosal recessions [5]. At the same time, another
retrospective evaluation of 250 implants after 5 to
10 years of functional loading demonstrated a negative
correlation between the presence of keratinized tissue
and mucosal recessions [6]. Consequently, it is safe to
say that sufficient peri-implant keratinized tissue pre-
vents peri-implant plaque accumulation and buccal soft
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tissue recessions, accordingly reducing the risk of mucositis
and peri-implantitis [7, 8]. A surgical technique based on
an apically positioned flap (APF) for vestibuloplasty associ-
ated with grafting materials (whether autologous or not) is
considered the gold standard for soft tissue augmentation
[9]. While a number of autologous grafts have been studied
in the past, free gingival grafts from the palatal region are
considered the most reliable and effective, in spite of the
high morbidity of this type of surgery and extremely poor
esthetics [10, 11]. In the past few years, collagen matrices
(CM) have been studied as a valid substitute for free
gingival grafts, in particular the porcine CM Mucograft
(Geistlich Biomaterials GmbH, Baden-Baden, Germany). So
far, a number of studies have demonstrated that the
Mucograft is reliable and comparable with free gingival graft
for what concerns achievements in keratinized tissue aug-
mentation around both teeth or dental implants [12–15].
Additional advantages are a lower patient morbidity due to
the absence of a donor site and the high esthetic value,
matching texture and color of the adjacent mucosa [11,
15–17]. Concerns about long-term stability of this kind of
procedure are more than reasonable, as the majority of
papers in literature have short-term follow-ups (< 1 year),
while just a few extend over this period. The aim of the
present research is to evaluate the efficacy of the Mucograft
in a standard APF procedure over 5 years of follow-up.
Methods
The study was designed as a multicentered (Milan
University—School of Dentistry/Loma Linda University—
School of Dentistry) prospective observational (non-
controlled) clinical study according to the STROBE
criteria. The participants of the study presented areas
of deficient attached and unattached mucosa preclud-
ing the construction of effective functioning pros-
thesis. The study included a total of 15 patients, both
female and male, who were candidates for mucosal soft
tissue augmentation by means of a xenogeneic CM
(Geistlich Mucograft®, Geistlich Pharma AG, Wolhusen,
CH). Patients included had to be at least 18 years old, both
systemically and periodontally healthy with good oral hy-
giene; patients who were heavy smokers or bore systemic
diseases that could influence bone turnover/wound
healing were excluded. The purpose of the surgery was to
improve the quantity of attached and unattached mucosa
in order to facilitate the final prosthetic rehabilitation. The
entire study was reviewed and approved by the Ethics
Committee of the IRCCS Ospedale Maggiore Policlinico
di Milano, Fondazione Ca’ Granda. Written consent was
obtained at the recruitment visit from all the participants.
The material
The xenogeneic CM (Mucograft®) is a class III medical
device according to the Medical Device Directive 93/42
(EEC definitions: 1.1, long-term implant; 1.2, implantable;
8, resorbable; and 17, porcine origin). Its structure consists
of two functional layers: a cell occlusive layer consisting of
collagen fibers in a compact arrangement and a thick por-
ous layer. This porous layer provides a space that favors
the formation of a blood clot and the ingrowth of tissue
from adjacent sites. This xenogenic graft has been cleared
by the EU and US Food and Drug Administration for
regenerative therapy involving teeth and implants.
The surgical procedure
The surgical procedure, as already described in a previous
study, consisted in a standard apically positioned flap with
subsequent apposition of the CM, performed under local
anesthesia [17]. At first, a midcrestal incision was per-
formed in the residual keratinized band and a split thick-
ness flap was raised. Any muscle fibers and fibrous
banding attached in the area were dissected from the peri-
osteum and were reduced toward the depth of the vesti-
bule. In addition, submucosal fatty tissue was also
dissected from the periosteum over the bone in the area.
The lateral portion of the mucosal flap was sutured to the
periosteum in the depth of vestibule. The denuded area of
the wound in the vestibule was then covered by the CM.
The CM was sutured to the surrounding mucosa an-
teriorly, posteriorly, and in the vestibular direction. The
suturing was by 5–0 nylon. Approximately half of these
sutures were allowed to remain in place for a period of
4 to 6 weeks to determine the outline of the original
periphery of the incision and “graft” post-operatively.
This was important in determining the area of actual
re-epithelization of the defect and in determining and
quantifying any shrinkage by scarring in the grafted
area. Time was taken from the first incision to the last su-
ture to record and compare the surgery length. A previously
prepared acrylic splint was placed over the vestibuloplasty
site at the time of surgery. This splint remained in place for
10 days at which time it was removed. The patient had to
irrigate the area with 0.9% NaCl solution for those 10 days
and rinse with 0.2% chlorhexidine.
Specific endpoints and clinical follow-up
The primary endpoints were to evaluate the shrinkage
degree of the width of keratinized mucosa and length of
the re-epithelization process. The secondary endpoints
assessed clinical evaluation of the grafted area, post-
operative hemostatic effect, pain level, and length of sur-
gery. Follow-up control visits were scheduled at 3 days
after surgery and then 10 days, 2 weeks, 3 weeks,
1 month, 2 months, 6 months, 1 year, and 4 and 5 years
as showed by the clinical case reported in Fig. 1. At each
examination time point, the width of keratinized tissue
(recorded from the crestal to the apical sutures; 3 to 5
measurement from mesial to distal) and vestibular depth
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were recorded by means of a 15-mm North Carolina
periodontal probe. Once the implants were placed,
measurement was taken from the free gingival margin,
at the prosthetical crown’s zenith. Re-epithelization was
evaluated clinically after 4 weeks on a scale from excel-
lent (100% of the grafted area) to poor (< 40%). The de-
gree of healing and maturation of tissues were observed
and compared to the physiological healing time. Digital
pictures were taken at each examination for comparison
with the adjacent soft tissue. Hemostatic effect and pain
level, evaluated using the Mankoski Pain Scale (from 0
to 10 where 0 is “No Pain” and 10 is “Pain makes you
pass out”), were recorded until the 10th day (or when-
ever an increase of discomfort/bleeding was reported by
the patient); examination time point in which the pro-
tective acrylic splint was removed [18]. Sutures were left
in place for 4 weeks in order to facilitate the recording
during healing. In all cases, dental implants were placed
2 months after the CM grafting elevating a full-thickness
flap accessing the crestal bone. No differences between
the original and the newly formed keratinized tissue
were clearly appreciable so the flap was designed without
any particular modifications. No bone grafting procedures
were needed. Healing abutments were placed following
a golden standard protocol, consisting in 4 months
healing for the maxillary implants and 3 months for the
mandibular ones.
Statistical significance
Since a split-mouth design was not feasible and the de-
fects being corrected by the mucosa particularly in the
vestibular portion of the study are not usually symmet-
rical or bilateral, the use of paired subjects was not a re-
liable format. All the data were analyzed with IBM’s
SPSS Statistics using ANOVA Repeated Measurements
statistical method. Mean values for keratinized mucosal
Fig. 1 a Pre-op. b Post-op. c Two weeks after surgery. d Four weeks after surgery. e Six months after surgery. f One year after surgery. g Four
years after surgery. h Five years after surgery
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width and probing depth were recorded in millimeters
at each examination time point and subsequently
expressed in a percentage. First measurement for kerati-
nized tissue, recorded immediately after surgery, was
considered as 100%. Less than 20% of contraction was
considered as excellent value, while good when less than
50%, fair to poor when higher than 50%, and unsatisfac-
tory when the graft was lost.
Results
A total of 15 patients were enrolled for the study, 12 fe-
males and 3 males, aged between 43 and 72 years old.
Of these patients, 11 received surgery in the mandible
and 4 in the maxilla. No complications were registered
during surgeries and the immediate post-operative
course was uneventful for all patients. At 1 year, 2 pa-
tients dropped out of the study: the first patient experi-
enced a peri-implantitis that was solved with a
conventional free gingival graft procedure while the sec-
ond one developed peri-implant pockets with perimuco-
sitis, making the 1-year analysis possible only on 13
patients. No allergic reactions were registered during the
clinical trial. The average keratinized tissue width before
surgery was 0.4 mm. The initial gain in keratinized tissue
(as measured immediately post-op) was 5.7 mm. Con-
stant contraction of the grafted area, and decrease in
keratinized tissue width, could be observed throughout
5 years of follow-up (Fig. 2). The initial 6 months were
the most critical, with the highest reduction, resulting in
a mean of 2.2 mm loss (37%) of value. Another 0.5 mm
were lost in the following 6 months (leading to the 1 year
examination time point), raising the value of contraction
to 48%. After 1 year, the contraction considerably slowed
down, with a further 11% width loss over the subsequent
4 years. The total loss after 5 years of follow-up was a
mean value of 3.3 mm, corresponding to 59% of the ini-
tial measurement (Fig. 3). Clinically, it was assessed that
the height of the keratinized tissue was, in any case,
lower than the adjacent sites. Re-epithelization was ex-
cellent and complete in most patients after 4 weeks
(Fig. 4). The matrix also proved to be a great hemostatic,
with no bleeding referred by subjects in the post-op
period. The procedure was short, with a mean operative
time of 20 min from first incision to last suture, and
painless, as referred by patients to the examiners during
the first two follow-ups (Mankoski Pain Scale value of
1–2). No visible difference in texture and color could be
found, after healing was complete, between the grafted
area and surrounding tissue, ensuring a great esthetic
outcome over the entire 5 years of follow-up.
Discussion
The study was carried out to evaluate the efficacy of a
xenogeneic CM when used as a soft tissue substitute in
the reconstruction of an adequate amount (at least
2 mm) of keratinized tissue around dental implants. The
xenogeneic CMs have already been investigated in order
to check their compatibility and effectiveness as scaffold
[19, 20]. One of the first studies was conducted by Schoo
and Coppes, who experimented the capacities of a
freeze-dried dura mater grafting material in stimulating
keratinized mucosa, with very poor results [21]. Two
studies by Harris, in 2001, analyzed the usefulness of
acellular dermal matrices when positioned upon the
Fig. 2 Average keratinized tissue (in mm)
Fig. 3 Shrinkage rate during time
Fig. 4 Re-epithelization at 4 weeks
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periosteum and bone [22, 23], without any particular re-
sults. Furthermore, in 2001, Wei P. and Laurell L. con-
ducted two studies: one clinical and one histological
[24]. Six patients received an autologous graft while the
remaining six an allogeneic one. The increment in ad-
herent mucosa was detectable in both groups, but the
gain was very little with the allogeneic graft. This was re-
lated to an excessive shrinkage of the graft post-operatively.
Histologically, it was observed that all grafted sites showed
a scar-like tissue, incapable of inducing cellular differenti-
ation. The fast resorption represented a big concern in this
technique leading to a disturbed healing and sequentially to
a lack of keratinized tissue. Harris et al. underlined the great
esthetic outcome in addition to the efficacy of substitutive
matrices for soft tissue [25]. Despite the physical and mech-
anical characteristics of these matrices are still under inves-
tigation, it has already been observed how these matrices
show statistically significant results confronted with the au-
tologous grafting techniques [26]. Comparable results were
observed evaluating not only by keratinized mucosa and
thickness and vestibular depth evaluation but also by histo-
logical study [27]: during the first week of healing, it has
been noticed a tissue remodeling due to phagocytosis of
pre-existing collagen fibers by macrophages. After 2 weeks,
new collagen fibers were detected as long as neoangiogen-
esis and re-epithelization on the membrane surface. At
4 weeks, it was difficult to find pre-existing collagen fibers.
At 10 weeks, the healing process was complete and the es-
thetic is already acceptable. Schmitt et al. achieved similar
outcomes in their study, which compared free gingival
grafts and a porcine CM [16]. At 90 days after surgery, bi-
opsies were harvested for histologic and immunohistolo-
gic analyses. It was observed the presence of specific
keratinized tissue markers is in the CM grafted areas.
CMs were also clinically tested as an alternative option for
root coverage. McGuire and Scheyer tested the CM asso-
ciated to a coronally advanced flap in recession defects
[28]. They find out how the porcine CM in combin-
ation with a coronal flap represented a satisfactory al-
ternative to autografts for covering dehiscence-type
recession defects. They also noticed a reduction of the
morbidity due to the absence of soft tissue graft har-
vesting. Nevins M. et al. tested the porcine CM around
a single tooth [11]. After 1 year from surgery, both
xenogeneic and autologous grafts healed perfectly,
showing mature connective tissue and the presence of
enough keratinized mucosa. The author underlined the
better esthetic outcome of the CM, which was showing
a perfect tissue integration. Herford et al. investigated
the efficacy of CMs for keratinized mucosa augmenta-
tion in cases of lack [29]. They demonstrated an over-
all mean shrinkage of 14% (range, 5 to 20%). Sanz et al.
confirmed how xenogeneic CMs guarantee predictable
and satisfactory results: their primary endpoint was to
evaluate the potentiality in gaining keratinized tissue
in comparison with an autologous graft [16]. At
6 months, they observed an insignificant statistical
variance between the autologous (60% shrinkage) and
the xenogeneic (67%). Despite the CM shrinkage range
is still very wide (from 14 to 75%), most of the authors
observed that the majority of shrinkage occurred in
the first month after surgery. In the present study, the
highest shrinkage rate was observed in the first
6 months (P = 0.002) while the following follow-up at
1, 4, and 5 years. The shrinkage was slower but
reached a final value of 59%, which is included in the
range observed in the other studies. In the present
paper, by analyzing the post-operative course, one fac-
tor is particularly highlighted: the great decrease in
morbidity. Post-operative pain in autologous grafting is
caused by the presence of a second surgical site, the
donor site. Most of the patients who underwent this
type surgery did not feel any pain at all, except a little
nuisance that required a mild analgesic as medication.
In the present study, the grafts were additionally cov-
ered with a vestibular retention splint. The use of the ves-
tibular retention splint guaranteed a mechanic protection
for the grafts. Moreover, it had a preventive effect on re-
insertion of vestibular muscle fibers. Despite the influence
of the splint on the width of keratinized mucosa has not
be taken in consideration in this study, Heberer et al. pre-
viously concluded its use after vestibuloplasty reduced the
graft shrinkage [30]. Furthermore, they observed a general
reduction of time of the surgery and post-op morbidity
too. The CM is extremely easy to use, with an average
length of surgery of 30 min, excluding anesthesia [16].
Intra-operative and post-operative bleeding was extremely
limited. The xenogeneic CM showed an ideal haemostatic
effect with no excessive bleeding during surgery and no
bleeding at all during post-operative period, similar to
other techniques using absorbable collagen sponges in dif-
ferent kinds of treatments [31]. Furthermore, all grafted
sites presented, when healing was completed, an optimal
integration with the surrounding tissues, as stated by
other authors in previous studies [15–17]. Rotundo an
Pini-Prato observed the good esthetic of the CM also
when used in the coverage of multiple gingival recession
[32]. Laino et al. described excellent results of CM in
wound repairing when placed after intraoral mucosal bi-
opsy [33]. Recently, Schmitt et al. observed the long-term
efficacy of CM when used in vestibuloplasty when com-
pared to free gingival graft [34]. Despite the free gingival
group showed lower values of keratinized tissue resorp-
tion, the CM showed good stability and better esthetic
outcomes. Further studies with a larger sample, investigat-
ing the long-term effectiveness of CMs and alternative
treatment options, should be performed in the future to
better assess a univocal outcome about the topic.
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Conclusions
With the limits of this study, it can be assessed that the
CM is an effective option for the keratinized tissue aug-
mentation. The percentage of shrinkage of the graft is
comparable to data recovered from other studies and
does not represent a problem also after 5 years. The CM
integration is slow and constant, providing the necessary
scaffold to regenerate keratinized mucosa and ensuring a
perfect healing. Patients reported no bleeding, and post-
operative morbidity was very low. Observing the grafted
areas, it is possible to notice the high esthetic result with-
out any dyschromia with the surrounding tissue. This
study shows that this type of CM can find major interest
in those patients who need a keratinized tissue augmenta-
tion around implants with great esthetic outcome or in
those who can bear little pain. Further studies will be ne-
cessary to assess definitively the efficacy and the applica-
tions of this material, eventually gaining statistical value.
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